Board of Directors

Peter Friedli is a co-founder of Osiris and, except for the period between February and June 2004, has been a director since January 1996. Mr. Friedli has been a principal of the investment-banking firm Friedli Corporate Finance, Inc., since 1986. Friedli Corporate Finance, Inc., a leading Swiss venture capital firm, has made significant investments in the biotechnology industry. Friedli Corporate Finance, Inc., has been the primary source of financing for Osiris. Mr. Friedli is also President of New Venturetec Ltd., a Swiss publicly traded investment company. Mr. Friedli has extensive experience as an independent investment manager in venture capital and has specialized in investments domiciled in the United States in the areas of biotechnology and technology. Prior to this, he worked in the field of international management consulting for service and industrial companies in Europe and the United States. He also serves as a director in certain private companies. Mr. Friedli is also the largest single shareholder.

Yves Huwyler was recently elected to the Board of Directors in 2015. Mr. Huwyler is an independent consultant for private equity and venture investments in the area of biotechnology and technology. He is the owner of Huwyler Private Equity GmbH, a specialized firm for private equity services based in Zurich, Switzerland. Mr. Huwyler was a Director at Friedli Corporate Finance until 2012. Mr. Huwyler has over 18 years of experience in private equity investing in various sectors and at all stages, predominantly in the United States and Europe. Mr. Huwyler is actively involved in the management of a number of companies and is a member of the Board of Directors of Prolexys Pharmaceuticals, Inc. Mr. Huwyler holds a master degree in economics and finance from the University of Zurich.

Jay M. Moyes was elected to the Board of Directors in 2006. Recently, Mr. Moyes served as the Chief Financial Officer of XDx. Prior to that, he served as the Chief Financial Officer of Myriad Genetics, Inc., from 1996 through 2007, and also as Myriad's Vice President of Finance from 1993 until 2005. From 1991 to 1993, Mr. Moyes served as Vice President of Finance and Chief Financial Officer of Genmark, Inc. Mr. Moyes held various positions with the accounting firm of KPMG, LLP, from 1979 through 1991. He holds an M.B.A. from the University of Utah and a Bachelor of Arts in economics from Weber State University, and was formerly a certified public accountant. Mr. Moyes is a current member of the Utah Association of Certified Public Accountants, and also served as a member of the Board of Trustees of the Utah Life Science Association from 1999 through 2006.

Thomas M. Brandt was recently elected to the Board of Directors in 2016. Mr. Brandt served as a board member for TeleCommunication Systems Inc. (TCS; NASDAQ:TSYS) from 2009 until its sale to Comtech Telecommunications in February, 2016, and was Chief Financial Officer for the company beginning in 1997.  He led TCS through an IPO in 2000 and helped the company grow from $25 million of revenue in 1998 to nearly $400 million in 2015.  Prior to his role at TeleCommunication Systems, Mr. Brandt was CFO of Digex, Inc., an internet service provider, where he helped lead its 1996 IPO.  Earlier in his career, he worked in the audit practice of Price Waterhouse for 12 years. He has more than three decades of experience enhancing corporate performance through alignment of corporate finance strategies with organizational objectives.  Mr. Brandt currently serves as a member of the boards of Antenna Research Associates and the YMCA of Central Maryland, as well as on Silicon Valley Bank’s CFO Advisory Board.  Mr. Brandt is a CPA with a bachelor’s degree in management science from Duke University and an MBA from the Wharton School of the University of Pennsylvania.